Our Customers

Cresset customers are focused on the design and discovery of small molecules that interact with biological targets. Our Field point descriptions of molecules give scientists a powerful method for analysing and comparing molecules that may or may not come from the same chemical series but which elicit similar biological effects.

Our customer base has grown steadily since our founding in 2002 and now Cresset science is in daily use in major pharmaceutical and biotech companies across the world from Europe to the USA and Japan. Increasingly our science is helping drug discovery companies to gain a critical advantage in the drug discovery process by adding insight and innovation to their projects.

Over the past two years we have been working hard to rearchitect our technology so that it can keep up with the changing world. We have incorporated distributed computing (including cloud deployments), command line interfaces and APIs to support workflow and script based deployment and flexible licensing policies to give you the most freedom to use our products as a central part of your day-to-day discovery efforts.

Cresset’s core applications may be focused on Computational Chemists but our technology is used to help Medicinal Chemists, Research Managers, Patent Attorneys, Safety teams and In-Licencing executives choose the best chemical entities by using biological activity rather than chemical similarity as the key descriptor of molecules.